 
        No significant effect of peri-operative pregabalin on post-op pain and clinical outcomes after TKA
 
                                                    No significant effect of peri-operative pregabalin on post-op pain and clinical outcomes after TKA
Perioperative pregabalin does not reduce opioid requirements in total knee arthroplasty
Knee Surg Sports Traumatol Arthrosc. 2019 Jul;27(7):2104-2110.Synopsis
87 patients with osteoarthritis and scheduled for total knee arthroplasty (TKA) were randomized to receive oral peri-operative pregabalin or placebo for the reduction of opioid consumption and pain following surgery. The primary outcome of interest was cumulative morphine consumption during the first 72 hours post-operation. Secondary outcomes of interest included pain on a Visual Analog Scale (VA...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.